prednisolone has been researched along with Cocarcinogenesis in 2 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Cocarcinogenesis: The combination of two or more different factors in the production of cancer.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Juasook, A | 1 |
Boonmars, T | 1 |
Wu, Z | 1 |
Loilome, W | 1 |
Veteewuthacharn, K | 1 |
Namwat, N | 1 |
Sudsarn, P | 1 |
Wonkchalee, O | 1 |
Sriraj, P | 1 |
Aukkanimart, R | 1 |
Matano, S | 1 |
Nakamura, S | 1 |
Kobayashi, K | 1 |
Misaki, T | 1 |
Matsuda, T | 1 |
Sugimoto, T | 1 |
2 other studies available for prednisolone and Cocarcinogenesis
Article | Year |
---|---|
Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine.
Topics: Animals; Bile Duct Neoplasms; Cell Transformation, Neoplastic; Cholangiocarcinoma; Chronic Disease; | 2013 |
Decreased lymphocytic proliferation by mitogens in patients with transitional cell carcinoma of the renal pelvis subsequent to non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchial Neoplasms; Carcinoma, Transitional C | 1996 |